XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Description of Business and Basis of Presentation (Details)
Mar. 11, 2021
USD ($)
$ / shares
shares
Dec. 21, 2020
$ / shares
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Mar. 10, 2021
$ / shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]          
Accumulated deficit | $     $ 335,753,000 $ 303,356,000  
Schedule of Reverse Recapitalization [Line Items]          
Accumulated deficit | $     $ (335,753,000) $ (303,356,000)  
Common stock, shares outstanding (in shares) 161,449,205   173,602,503 172,200,417  
Common stock, shares issued (in shares)     173,602,503 172,200,417  
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001  
Warrants outstanding (in shares) 15,999,996        
Preferred stock, par value (in dollars per share) | $ / shares     $ 0.0001    
Common stock, deemed value (in dollars per share) | $ / shares $ 10.00        
Gross proceeds from merger and private offering | $ $ 299,900,000        
Pre-merger cost | $ 8,500,000        
Offering cost | $ 26,600,000        
Private Placement          
Schedule of Reverse Recapitalization [Line Items]          
Common stock, deemed value (in dollars per share) | $ / shares   $ 10.00      
Sale of stock, number of shares issued in transaction (in shares)   10,000,000      
Sale of stock, aggregate commitment amount | $ $ 100,000,000        
Common Stock          
Schedule of Reverse Recapitalization [Line Items]          
Stock converted (in shares) 150,000,000        
CLA | CLA Warrants          
Schedule of Reverse Recapitalization [Line Items]          
Warrants outstanding (in shares)   10,000,000      
CLA | Private Placement Warrants          
Schedule of Reverse Recapitalization [Line Items]          
Warrants outstanding (in shares)   6,000,000      
CLA | Conversion of Class B Common Stock to Class A Common Stock          
Schedule of Reverse Recapitalization [Line Items]          
Ordinary shares, conversion ratio   1      
CLA | Conversion of Class A Common Stock to Common Stock          
Schedule of Reverse Recapitalization [Line Items]          
Ordinary shares, conversion ratio   1      
CLA | Conversion of Warrant to Ouster Common Stock          
Schedule of Reverse Recapitalization [Line Items]          
Warrant, conversion ratio   1      
CLA | Conversion of Canceled CLA Units to Ouster Common Stock          
Schedule of Reverse Recapitalization [Line Items]          
Unit, conversion ratio   1      
CLA | Conversion of Canceled CLA Units to Public Warrant          
Schedule of Reverse Recapitalization [Line Items]          
Unit, conversion ratio   0.5      
CLA | Common Class B          
Schedule of Reverse Recapitalization [Line Items]          
Common stock, shares outstanding (in shares)   5,000,000      
Common stock, shares issued (in shares)   5,000,000      
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001      
CLA | Common Class A          
Schedule of Reverse Recapitalization [Line Items]          
Common stock, shares outstanding (in shares)   25,000,000      
Common stock, shares issued (in shares)   25,000,000      
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001      
OTI          
Schedule of Reverse Recapitalization [Line Items]          
Common stock, par value (in dollars per share) | $ / shares         $ 0.00001
OTI | Series B Preferred Stock Converted to Common Stock          
Schedule of Reverse Recapitalization [Line Items]          
Preferred stock, conversion ratio         1
OTI | Series B Redeemable Convertible Preferred Stock          
Schedule of Reverse Recapitalization [Line Items]          
Preferred stock, par value (in dollars per share) | $ / shares         $ 0.00001